|
G |
ABCB1 |
ATP binding cassette subfamily B member 1 |
multiple interactions |
EXP |
rhodioloside affects the reaction [ABCB1 protein results in increased transport of Digoxin] |
CTD |
PMID:24380838 |
|
NCBI chr 7:87,503,017...87,713,295
Ensembl chr 7:87,503,017...87,713,323
|
|
G |
ABCB11 |
ATP binding cassette subfamily B member 11 |
multiple interactions |
ISO |
[furan co-treated with rhodioloside] results in increased expression of ABCB11 mRNA |
CTD |
PMID:32251705 |
|
NCBI chr 2:168,915,390...169,031,324
Ensembl chr 2:168,915,498...169,031,324
|
|
G |
ACHE |
acetylcholinesterase (Yt blood group) |
multiple interactions |
ISO |
rhodioloside inhibits the reaction [Isoflurane results in increased activity of ACHE protein] |
CTD |
PMID:28084090 |
|
NCBI chr 7:100,889,994...100,896,994
Ensembl chr 7:100,889,994...100,896,974
|
|
G |
AKT1 |
AKT serine/threonine kinase 1 |
multiple interactions |
ISO |
2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [rhodioloside inhibits the reaction [Colistin results in decreased phosphorylation of AKT1 protein]]; rhodioloside inhibits the reaction [Colistin results in decreased phosphorylation of AKT1 protein] |
CTD |
PMID:28465020 |
|
NCBI chr14:104,769,349...104,795,748
Ensembl chr14:104,769,349...104,795,759
|
|
G |
ALPL |
alkaline phosphatase, biomineralization associated |
increases activity increases expression |
ISO |
rhodioloside results in increased activity of ALPL protein rhodioloside results in increased expression of ALPL mRNA |
CTD |
PMID:24055767 |
|
NCBI chr 1:21,508,984...21,578,410
Ensembl chr 1:21,509,397...21,578,410
|
|
G |
AOC1 |
amine oxidase copper containing 1 |
decreases secretion |
ISO |
rhodioloside results in decreased secretion of AOC1 protein |
CTD |
PMID:37530723 |
|
NCBI chr 7:150,852,120...150,861,504
Ensembl chr 7:150,824,627...150,861,504
|
|
G |
BAX |
BCL2 associated X, apoptosis regulator |
multiple interactions |
ISO EXP |
rhodioloside inhibits the reaction [Doxorubicin results in increased expression of BAX mRNA] rhodioloside inhibits the reaction [1-Methyl-4-phenylpyridinium results in increased expression of BAX protein]; sirtinol inhibits the reaction [rhodioloside inhibits the reaction [1-Methyl-4-phenylpyridinium results in increased expression of BAX protein]] 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [rhodioloside inhibits the reaction [Colistin results in increased expression of BAX protein]]; rhodioloside inhibits the reaction [cobaltous chloride results in increased expression of BAX protein]; rhodioloside inhibits the reaction [Colistin results in increased expression of BAX protein]; rhodioloside inhibits the reaction [Doxorubicin results in increased expression of BAX mRNA]; rhodioloside inhibits the reaction [Doxorubicin results in increased expression of BAX protein] |
CTD |
PMID:21499890 PMID:24072175 PMID:28465020 PMID:28851138 |
|
NCBI chr19:48,954,875...48,961,798
Ensembl chr19:48,954,815...48,961,798
|
|
G |
BCL2 |
BCL2 apoptosis regulator |
increases expression multiple interactions |
ISO EXP |
rhodioloside results in increased expression of BCL2 mRNA rhodioloside inhibits the reaction [1-Methyl-4-phenylpyridinium results in decreased expression of BCL2 protein]; sirtinol inhibits the reaction [rhodioloside inhibits the reaction [1-Methyl-4-phenylpyridinium results in decreased expression of BCL2 protein]] 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [rhodioloside inhibits the reaction [Colistin results in decreased expression of BCL2 protein]]; rhodioloside inhibits the reaction [Colistin results in decreased expression of BCL2 protein]; rhodioloside inhibits the reaction [Doxorubicin results in decreased expression of BCL2 mRNA] rhodioloside results in increased expression of BCL2 protein |
CTD |
PMID:24072175 PMID:28465020 PMID:28851138 |
|
NCBI chr18:63,123,346...63,320,090
Ensembl chr18:63,123,346...63,320,128
|
|
G |
BMP2 |
bone morphogenetic protein 2 |
increases expression |
ISO |
rhodioloside results in increased expression of BMP2 mRNA |
CTD |
PMID:24055767 |
|
NCBI chr20:6,767,686...6,780,246
Ensembl chr20:6,767,686...6,780,246
|
|
G |
BMP6 |
bone morphogenetic protein 6 |
increases expression |
ISO |
rhodioloside results in increased expression of BMP6 mRNA |
CTD |
PMID:24055767 |
|
NCBI chr 6:7,726,099...7,881,728
Ensembl chr 6:7,726,099...7,881,728
|
|
G |
BMP7 |
bone morphogenetic protein 7 |
increases expression |
ISO |
rhodioloside results in increased expression of BMP7 mRNA |
CTD |
PMID:24055767 |
|
NCBI chr20:57,168,753...57,266,641
Ensembl chr20:57,168,753...57,266,641
|
|
G |
CASP1 |
caspase 1 |
multiple interactions |
ISO |
rhodioloside inhibits the reaction [Glucose results in increased expression of CASP1 protein] rhodioloside inhibits the reaction [furan results in increased cleavage of CASP1 protein] |
CTD |
PMID:29031534 PMID:34450210 |
|
NCBI chr11:105,025,443...105,036,686
Ensembl chr11:105,025,397...105,035,250
|
|
G |
CASP12 |
caspase 12 (gene/pseudogene) |
multiple interactions |
ISO |
rhodioloside inhibits the reaction [furan results in increased cleavage of CASP12 protein] |
CTD |
PMID:34450210 |
|
NCBI chr11:104,883,286...104,898,460
Ensembl chr11:104,885,718...104,898,670
|
|
G |
CASP3 |
caspase 3 |
multiple interactions |
ISO EXP |
2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [rhodioloside inhibits the reaction [Colistin results in increased activity of and results in increased cleavage of CASP3 protein]]; rhodioloside inhibits the reaction [[manganese chloride results in increased abundance of Manganese] which results in increased cleavage of CASP3 protein]; rhodioloside inhibits the reaction [Colistin results in increased activity of and results in increased cleavage of CASP3 protein]; rhodioloside inhibits the reaction [Doxorubicin results in increased cleavage of CASP3 protein] rhodioloside inhibits the reaction [1-Methyl-4-phenylpyridinium results in increased activity of CASP3 protein]; sirtinol inhibits the reaction [rhodioloside inhibits the reaction [1-Methyl-4-phenylpyridinium results in increased activity of CASP3 protein]] |
CTD |
PMID:24072175 PMID:28465020 PMID:28851138 PMID:30991096 |
|
NCBI chr 4:184,627,696...184,649,447
Ensembl chr 4:184,627,696...184,650,062
|
|
G |
CAT |
catalase |
increases expression multiple interactions |
ISO |
rhodioloside results in increased expression of CAT mRNA; rhodioloside results in increased expression of CAT protein rhodioloside inhibits the reaction [furan results in decreased activity of CAT protein]; rhodioloside inhibits the reaction [furan results in decreased expression of CAT mRNA]; rhodioloside inhibits the reaction [Streptozocin results in decreased activity of CAT protein] |
CTD |
PMID:24072175 PMID:31682803 PMID:34450210 |
|
NCBI chr11:34,438,934...34,472,060
Ensembl chr11:34,438,934...34,472,060
|
|
G |
CDH2 |
cadherin 2 |
multiple interactions |
ISO |
rhodioloside inhibits the reaction [Streptozocin results in decreased expression of CDH2 protein] |
CTD |
PMID:31682803 |
|
NCBI chr18:27,932,879...28,177,130
Ensembl chr18:27,932,879...28,177,946
|
|
G |
CERT1 |
ceramide transporter 1 |
multiple interactions |
ISO |
rhodioloside inhibits the reaction [Glucose results in increased expression of CERT1 mRNA] |
CTD |
PMID:29031534 |
|
NCBI chr 5:75,368,486...75,511,981
Ensembl chr 5:75,356,345...75,512,138
|
|
G |
CHAT |
choline O-acetyltransferase |
multiple interactions |
ISO |
rhodioloside inhibits the reaction [Isoflurane results in decreased activity of CHAT protein] |
CTD |
PMID:28084090 |
|
NCBI chr10:49,609,095...49,667,942
Ensembl chr10:49,609,095...49,667,942
|
|
G |
CLDN11 |
claudin 11 |
multiple interactions |
ISO |
rhodioloside inhibits the reaction [Streptozocin results in decreased expression of CLDN11 protein] |
CTD |
PMID:31682803 |
|
NCBI chr 3:170,418,868...170,434,691
Ensembl chr 3:170,418,868...170,454,733
|
|
G |
CYBB |
cytochrome b-245 beta chain |
multiple interactions |
EXP |
rhodioloside inhibits the reaction [1-Methyl-4-phenylpyridinium results in decreased expression of CYBB protein]; sirtinol inhibits the reaction [rhodioloside inhibits the reaction [1-Methyl-4-phenylpyridinium results in decreased expression of CYBB protein]] |
CTD |
PMID:28851138 |
|
NCBI chr X:37,780,059...37,813,461
Ensembl chr X:37,780,018...37,813,461
|
|
G |
CYP2E1 |
cytochrome P450 family 2 subfamily E member 1 |
multiple interactions |
ISO |
rhodioloside inhibits the reaction [furan results in increased expression of CYP2E1 protein] |
CTD |
PMID:34450210 |
|
NCBI chr10:133,527,363...133,539,123
Ensembl chr10:133,520,406...133,561,220
|
|
G |
CYP7A1 |
cytochrome P450 family 7 subfamily A member 1 |
multiple interactions |
ISO |
rhodioloside inhibits the reaction [furan results in decreased expression of CYP7A1 mRNA] |
CTD |
PMID:32251705 |
|
NCBI chr 8:58,490,178...58,500,163
Ensembl chr 8:58,490,178...58,500,163
|
|
G |
DDIT3 |
DNA damage inducible transcript 3 |
multiple interactions |
ISO |
rhodioloside inhibits the reaction [furan results in increased expression of DDIT3 mRNA]; rhodioloside inhibits the reaction [furan results in increased expression of DDIT3 protein] |
CTD |
PMID:34450210 |
|
NCBI chr12:57,516,588...57,520,517
Ensembl chr12:57,516,588...57,521,737
|
|
G |
DDIT4 |
DNA damage inducible transcript 4 |
multiple interactions |
ISO |
rhodioloside inhibits the reaction [[cobaltous chloride co-treated with NGF protein] results in increased expression of DDIT4 mRNA]; rhodioloside inhibits the reaction [[cobaltous chloride co-treated with NGF protein] results in increased expression of DDIT4 protein] |
CTD |
PMID:24989011 |
|
NCBI chr10:72,273,924...72,276,036
Ensembl chr10:72,273,919...72,276,036
|
|
G |
ENO2 |
enolase 2 |
multiple interactions increases expression |
ISO |
N-(N-(3,5-difluorophenacetyl)alanyl)phenylglycine tert-butyl ester promotes the reaction [rhodioloside results in increased expression of ENO2 mRNA]; NOG protein inhibits the reaction [rhodioloside results in increased expression of ENO2 mRNA]; NOG protein inhibits the reaction [rhodioloside results in increased expression of ENO2 protein] rhodioloside results in increased expression of ENO2 mRNA; rhodioloside results in increased expression of ENO2 protein |
CTD |
PMID:24929042 |
|
NCBI chr12:6,914,580...6,923,697
Ensembl chr12:6,913,745...6,923,698
|
|
G |
ERN1 |
endoplasmic reticulum to nucleus signaling 1 |
multiple interactions |
ISO |
rhodioloside inhibits the reaction [furan results in increased phosphorylation of ERN1 protein] |
CTD |
PMID:34450210 |
|
NCBI chr17:64,039,142...64,130,144
Ensembl chr17:64,039,080...64,130,819
|
|
G |
FGF19 |
fibroblast growth factor 19 |
multiple interactions |
ISO |
[furan co-treated with rhodioloside] results in increased expression of FGF15 mRNA |
CTD |
PMID:32251705 |
|
NCBI chr11:69,698,238...69,704,022
Ensembl chr11:69,698,238...69,704,022
|
|
G |
FN1 |
fibronectin 1 |
multiple interactions |
ISO |
rhodioloside inhibits the reaction [Glucose results in increased expression of FN1 mRNA] |
CTD |
PMID:29031534 |
|
NCBI chr 2:215,360,865...215,436,068
Ensembl chr 2:215,360,440...215,436,073
|
|
G |
HES1 |
hes family bHLH transcription factor 1 |
decreases expression |
ISO |
rhodioloside results in decreased expression of HES1 mRNA |
CTD |
PMID:24929042 |
|
NCBI chr 3:194,136,148...194,138,732
Ensembl chr 3:194,136,148...194,138,732
|
|
G |
HIF1A |
hypoxia inducible factor 1 subunit alpha |
multiple interactions |
ISO |
[rhodioloside co-treated with cobaltous chloride co-treated with NGF protein] results in decreased expression of HIF1A mRNA; R 59949 inhibits the reaction [rhodioloside promotes the reaction [cobaltous chloride results in increased expression of and affects the localization of HIF1A protein]]; rhodioloside inhibits the reaction [[cobaltous chloride co-treated with NGF protein] results in increased expression of HIF1A protein]; rhodioloside promotes the reaction [cobaltous chloride results in increased expression of and affects the localization of HIF1A protein] |
CTD |
PMID:21499890 PMID:24989011 |
|
NCBI chr14:61,695,513...61,748,258
Ensembl chr14:61,695,513...61,748,259
|
|
G |
HSPA5 |
heat shock protein family A (Hsp70) member 5 |
multiple interactions |
ISO |
rhodioloside inhibits the reaction [furan results in increased expression of HSPA5 mRNA]; rhodioloside inhibits the reaction [furan results in increased expression of HSPA5 protein] |
CTD |
PMID:34450210 |
|
NCBI chr 9:125,234,853...125,241,343
Ensembl chr 9:125,234,853...125,241,382
|
|
G |
IL18 |
interleukin 18 |
multiple interactions |
ISO |
rhodioloside inhibits the reaction [furan results in increased expression of IL18 mRNA]; rhodioloside inhibits the reaction [furan results in increased expression of IL18 protein] |
CTD |
PMID:34450210 |
|
NCBI chr11:112,143,260...112,164,094
Ensembl chr11:112,143,253...112,164,096
|
|
G |
IL1B |
interleukin 1 beta |
multiple interactions |
ISO |
rhodioloside inhibits the reaction [Isoflurane results in increased expression of IL1B protein] rhodioloside inhibits the reaction [furan results in increased expression of IL1B mRNA]; rhodioloside inhibits the reaction [furan results in increased expression of IL1B protein]; rhodioloside results in decreased secretion of and results in decreased expression of IL1B protein |
CTD |
PMID:28084090 PMID:34450210 PMID:37530723 |
|
NCBI chr 2:112,829,751...112,836,779
Ensembl chr 2:112,829,751...112,836,816
|
|
G |
IL6 |
interleukin 6 |
multiple interactions |
ISO |
rhodioloside inhibits the reaction [furan results in increased expression of IL6 mRNA]; rhodioloside results in decreased secretion of and results in decreased expression of IL6 protein |
CTD |
PMID:34450210 PMID:37530723 |
|
NCBI chr 7:22,727,200...22,731,998
Ensembl chr 7:22,725,884...22,732,002
|
|
G |
MAP2 |
microtubule associated protein 2 |
multiple interactions increases expression |
ISO |
N-(N-(3,5-difluorophenacetyl)alanyl)phenylglycine tert-butyl ester promotes the reaction [rhodioloside results in increased expression of MAP2 mRNA]; NOG protein inhibits the reaction [rhodioloside results in increased expression of MAP2 mRNA]; NOG protein inhibits the reaction [rhodioloside results in increased expression of MAP2 protein] rhodioloside results in increased expression of MAP2 mRNA; rhodioloside results in increased expression of MAP2 protein |
CTD |
PMID:24929042 |
|
NCBI chr 2:209,424,047...209,734,112
Ensembl chr 2:209,424,047...209,734,147
|
|
G |
MAP3K5 |
mitogen-activated protein kinase kinase kinase 5 |
multiple interactions |
ISO |
rhodioloside inhibits the reaction [furan results in increased phosphorylation of MAP3K5 protein] |
CTD |
PMID:34450210 |
|
NCBI chr 6:136,557,046...136,793,091
Ensembl chr 6:136,557,046...136,793,097
|
|
G |
MAPK1 |
mitogen-activated protein kinase 1 |
multiple interactions |
ISO |
rhodioloside inhibits the reaction [furan results in increased phosphorylation of MAPK1 protein] |
CTD |
PMID:34450210 |
|
NCBI chr22:21,759,657...21,867,680
Ensembl chr22:21,759,657...21,867,680
|
|
G |
MAPK3 |
mitogen-activated protein kinase 3 |
multiple interactions |
ISO |
rhodioloside inhibits the reaction [furan results in increased phosphorylation of MAPK3 protein] |
CTD |
PMID:34450210 |
|
NCBI chr16:30,114,105...30,123,220
Ensembl chr16:30,114,105...30,123,506
|
|
G |
MAPK8 |
mitogen-activated protein kinase 8 |
multiple interactions |
ISO |
rhodioloside inhibits the reaction [furan results in increased phosphorylation of MAPK8 protein] |
CTD |
PMID:34450210 |
|
NCBI chr10:48,306,677...48,439,360
Ensembl chr10:48,306,639...48,439,360
|
|
G |
MTOR |
mechanistic target of rapamycin kinase |
multiple interactions |
ISO |
Everolimus inhibits the reaction [rhodioloside inhibits the reaction [[cobaltous chloride co-treated with NGF protein] results in decreased phosphorylation of MTOR protein]]; rhodioloside inhibits the reaction [[cobaltous chloride co-treated with NGF protein] results in decreased phosphorylation of MTOR protein] |
CTD |
PMID:24989011 |
|
NCBI chr 1:11,106,535...11,262,551
Ensembl chr 1:11,106,535...11,262,556
|
|
G |
NFKBIA |
NFKB inhibitor alpha |
multiple interactions |
ISO |
rhodioloside inhibits the reaction [furan results in increased phosphorylation of NFKBIA protein] |
CTD |
PMID:34450210 |
|
NCBI chr14:35,401,513...35,404,749
Ensembl chr14:35,401,079...35,404,749
|
|
G |
NGF |
nerve growth factor |
multiple interactions |
ISO |
[rhodioloside co-treated with cobaltous chloride co-treated with NGF protein] results in decreased expression of HIF1A mRNA; Everolimus inhibits the reaction [rhodioloside inhibits the reaction [[cobaltous chloride co-treated with NGF protein] results in decreased phosphorylation of MTOR protein]]; Everolimus inhibits the reaction [rhodioloside inhibits the reaction [[cobaltous chloride co-treated with NGF protein] results in decreased phosphorylation of RPS6KB1 protein]]; rhodioloside inhibits the reaction [[cobaltous chloride co-treated with NGF protein] results in decreased phosphorylation of MTOR protein]; rhodioloside inhibits the reaction [[cobaltous chloride co-treated with NGF protein] results in decreased phosphorylation of RPS6KB1 protein]; rhodioloside inhibits the reaction [[cobaltous chloride co-treated with NGF protein] results in increased expression of DDIT4 mRNA]; rhodioloside inhibits the reaction [[cobaltous chloride co-treated with NGF protein] results in increased expression of DDIT4 protein]; rhodioloside inhibits the reaction [[cobaltous chloride co-treated with NGF protein] results in increased expression of HIF1A protein] |
CTD |
PMID:24989011 |
|
NCBI chr 1:115,285,917...115,338,249
Ensembl chr 1:115,285,904...115,338,770
|
|
G |
NLRP3 |
NLR family pyrin domain containing 3 |
multiple interactions |
ISO |
rhodioloside inhibits the reaction [Glucose results in increased expression of NLRP3 protein] rhodioloside inhibits the reaction [furan results in increased expression of NLRP3 protein] |
CTD |
PMID:29031534 PMID:34450210 |
|
NCBI chr 1:247,416,077...247,448,817
Ensembl chr 1:247,332,331...247,449,108
|
|
G |
NOG |
noggin |
multiple interactions |
ISO |
NOG protein inhibits the reaction [rhodioloside results in increased expression of ENO2 mRNA]; NOG protein inhibits the reaction [rhodioloside results in increased expression of ENO2 protein]; NOG protein inhibits the reaction [rhodioloside results in increased expression of MAP2 mRNA]; NOG protein inhibits the reaction [rhodioloside results in increased expression of MAP2 protein]; NOG protein inhibits the reaction [rhodioloside results in increased expression of TUBB3 mRNA]; NOG protein inhibits the reaction [rhodioloside results in increased expression of TUBB3 protein] |
CTD |
PMID:24929042 |
|
NCBI chr17:56,593,699...56,595,611
Ensembl chr17:56,593,699...56,595,611
|
|
G |
NOTCH1 |
notch receptor 1 |
decreases expression |
ISO |
rhodioloside results in decreased expression of NOTCH1 mRNA |
CTD |
PMID:24929042 |
|
NCBI chr 9:136,494,433...136,546,048
Ensembl chr 9:136,494,433...136,546,048
|
|
G |
NOX1 |
NADPH oxidase 1 |
multiple interactions |
ISO |
rhodioloside inhibits the reaction [Doxorubicin results in increased expression of NOX1 mRNA] |
CTD |
PMID:24072175 |
|
NCBI chr X:100,843,324...100,874,359
Ensembl chr X:100,843,324...100,874,359
|
|
G |
NR0B2 |
nuclear receptor subfamily 0 group B member 2 |
multiple interactions |
ISO |
rhodioloside inhibits the reaction [furan results in increased expression of NR0B2 mRNA] |
CTD |
PMID:32251705 |
|
NCBI chr 1:26,911,489...26,913,975
Ensembl chr 1:26,911,489...26,913,975
|
|
G |
NR1H4 |
nuclear receptor subfamily 1 group H member 4 |
multiple interactions |
ISO |
rhodioloside affects the reaction [furan affects the expression of NR1H4 mRNA] |
CTD |
PMID:32251705 |
|
NCBI chr12:100,473,866...100,564,414
Ensembl chr12:100,473,708...100,564,414
|
|
G |
OCLN |
occludin |
multiple interactions |
ISO |
rhodioloside affects the reaction [furan results in decreased expression of OCLN protein]; rhodioloside inhibits the reaction [Streptozocin results in decreased expression of OCLN protein] |
CTD |
PMID:31682803 PMID:32251705 |
|
NCBI chr 5:69,492,547...69,558,104
Ensembl chr 5:69,492,292...69,558,104
|
|
G |
PRKAA1 |
protein kinase AMP-activated catalytic subunit alpha 1 |
multiple interactions |
ISO |
rhodioloside results in increased phosphorylation of [PRKAA1 protein binds to PRKAA2 protein] |
CTD |
PMID:37530723 |
|
NCBI chr 5:40,759,389...40,798,374
Ensembl chr 5:40,759,389...40,798,374
|
|
G |
PRKAA2 |
protein kinase AMP-activated catalytic subunit alpha 2 |
multiple interactions |
ISO |
rhodioloside results in increased phosphorylation of [PRKAA1 protein binds to PRKAA2 protein] |
CTD |
PMID:37530723 |
|
NCBI chr 1:56,645,314...56,715,335
Ensembl chr 1:56,645,314...56,715,335
|
|
G |
PRKAR2B |
protein kinase cAMP-dependent type II regulatory subunit beta |
multiple interactions |
ISO |
rhodioloside inhibits the reaction [[Oxygen co-treated with Glucose deficiency] results in decreased expression of PRKAR2B protein] |
CTD |
PMID:24726522 |
|
NCBI chr 7:107,044,705...107,161,811
Ensembl chr 7:107,044,705...107,161,811
|
|
G |
PYCARD |
PYD and CARD domain containing |
multiple interactions |
ISO |
rhodioloside inhibits the reaction [Glucose results in increased expression of PYCARD protein] rhodioloside inhibits the reaction [furan results in increased expression of PYCARD protein] |
CTD |
PMID:29031534 PMID:34450210 |
|
NCBI chr16:31,201,486...31,202,760
Ensembl chr16:31,201,486...31,203,450
|
|
G |
RELA |
RELA proto-oncogene, NF-kB subunit |
multiple interactions |
ISO |
rhodioloside inhibits the reaction [cobaltous chloride results in increased expression of RELA protein] rhodioloside inhibits the reaction [furan results in increased phosphorylation of RELA protein] |
CTD |
PMID:21499890 PMID:34450210 |
|
NCBI chr11:65,653,601...65,663,857
Ensembl chr11:65,653,599...65,663,090
|
|
G |
RPS6KB1 |
ribosomal protein S6 kinase B1 |
multiple interactions |
ISO |
Everolimus inhibits the reaction [rhodioloside inhibits the reaction [[cobaltous chloride co-treated with NGF protein] results in decreased phosphorylation of RPS6KB1 protein]]; rhodioloside inhibits the reaction [[cobaltous chloride co-treated with NGF protein] results in decreased phosphorylation of RPS6KB1 protein] |
CTD |
PMID:24989011 |
|
NCBI chr17:59,893,121...59,950,574
Ensembl chr17:59,893,046...59,950,574
|
|
G |
RUNX2 |
RUNX family transcription factor 2 |
increases expression increases activity |
ISO |
rhodioloside results in increased expression of RUNX2 mRNA rhodioloside results in increased activity of RUNX2 protein |
CTD |
PMID:24055767 |
|
NCBI chr 6:45,328,330...45,551,082
Ensembl chr 6:45,328,157...45,664,349
|
|
G |
SIRT1 |
sirtuin 1 |
multiple interactions |
EXP |
rhodioloside inhibits the reaction [1-Methyl-4-phenylpyridinium results in decreased expression of and results in decreased activity of SIRT1 protein] |
CTD |
PMID:28851138 |
|
NCBI chr10:67,884,656...67,918,390
Ensembl chr10:67,884,656...67,918,390
|
|
G |
SMAD1 |
SMAD family member 1 |
multiple interactions increases expression |
ISO |
rhodioloside results in increased phosphorylation of and results in increased expression of SMAD1 protein rhodioloside results in increased expression of SMAD1 mRNA |
CTD |
PMID:24929042 |
|
NCBI chr 4:145,480,770...145,559,176
Ensembl chr 4:145,481,194...145,559,176
|
|
G |
SMAD5 |
SMAD family member 5 |
increases expression multiple interactions |
ISO |
rhodioloside results in increased expression of SMAD5 mRNA rhodioloside results in increased phosphorylation of and results in increased expression of SMAD5 protein |
CTD |
PMID:24929042 |
|
NCBI chr 5:136,132,845...136,182,733
Ensembl chr 5:136,132,845...136,188,747
|
|
G |
SMAD9 |
SMAD family member 9 |
increases expression multiple interactions |
ISO |
rhodioloside results in increased expression of SMAD9 mRNA rhodioloside results in increased phosphorylation of and results in increased expression of SMAD9 protein |
CTD |
PMID:24929042 |
|
NCBI chr13:36,844,831...36,920,854
Ensembl chr13:36,844,831...36,920,887
|
|
G |
SOD1 |
superoxide dismutase 1 |
multiple interactions |
ISO |
rhodioloside inhibits the reaction [furan results in decreased expression of SOD1 mRNA] |
CTD |
PMID:34450210 |
|
NCBI chr21:31,659,693...31,668,931
Ensembl chr21:31,659,666...31,668,931
|
|
G |
SOD2 |
superoxide dismutase 2 |
increases expression |
ISO |
rhodioloside results in increased expression of SOD2 mRNA; rhodioloside results in increased expression of SOD2 protein |
CTD |
PMID:24072175 |
|
NCBI chr 6:159,669,069...159,762,281
Ensembl chr 6:159,669,069...159,762,529
|
|
G |
SP7 |
Sp7 transcription factor |
increases expression |
ISO |
rhodioloside results in increased expression of SP7 mRNA |
CTD |
PMID:24055767 |
|
NCBI chr12:53,326,575...53,344,793
Ensembl chr12:53,326,575...53,345,315
|
|
G |
SPP1 |
secreted phosphoprotein 1 |
increases expression |
ISO |
rhodioloside results in increased expression of SPP1 mRNA |
CTD |
PMID:24055767 |
|
NCBI chr 4:87,975,714...87,983,411
Ensembl chr 4:87,975,667...87,983,532
|
|
G |
TGFB1 |
transforming growth factor beta 1 |
multiple interactions |
ISO |
rhodioloside inhibits the reaction [Paraquat results in increased expression of TGFB1 mRNA]; rhodioloside inhibits the reaction [Paraquat results in increased expression of TGFB1 protein] |
CTD |
PMID:25674253 |
|
NCBI chr19:41,330,323...41,353,922
Ensembl chr19:41,301,587...41,353,922
|
|
G |
TJP1 |
tight junction protein 1 |
multiple interactions |
ISO |
rhodioloside inhibits the reaction [furan results in decreased expression of TJP1 protein]; rhodioloside inhibits the reaction [Streptozocin results in decreased expression of TJP1 protein] |
CTD |
PMID:31682803 PMID:32251705 |
|
NCBI chr15:29,699,367...29,969,049
Ensembl chr15:29,699,367...29,968,915
|
|
G |
TNF |
tumor necrosis factor |
multiple interactions |
ISO |
rhodioloside inhibits the reaction [Isoflurane results in increased expression of TNF protein] rhodioloside inhibits the reaction [furan results in increased expression of TNF mRNA]; rhodioloside results in decreased secretion of and results in decreased expression of TNF protein |
CTD |
PMID:28084090 PMID:34450210 PMID:37530723 |
|
NCBI chr 6:31,575,565...31,578,336
Ensembl chr 6:31,575,565...31,578,336
|
|
G |
TRAF2 |
TNF receptor associated factor 2 |
multiple interactions |
ISO |
rhodioloside inhibits the reaction [furan results in increased expression of TRAF2 protein] |
CTD |
PMID:34450210 |
|
NCBI chr 9:136,881,958...136,926,607
Ensembl chr 9:136,881,912...136,926,607
|
|
G |
TUBB3 |
tubulin beta 3 class III |
multiple interactions increases expression |
ISO |
N-(N-(3,5-difluorophenacetyl)alanyl)phenylglycine tert-butyl ester promotes the reaction [rhodioloside results in increased expression of TUBB3 mRNA]; NOG protein inhibits the reaction [rhodioloside results in increased expression of TUBB3 mRNA]; NOG protein inhibits the reaction [rhodioloside results in increased expression of TUBB3 protein] rhodioloside results in increased expression of TUBB3 mRNA; rhodioloside results in increased expression of TUBB3 protein |
CTD |
PMID:24929042 |
|
NCBI chr16:89,921,925...89,936,097
Ensembl chr16:89,921,392...89,938,761
|
|
G |
TXNIP |
thioredoxin interacting protein |
multiple interactions decreases expression |
ISO |
rhodioloside inhibits the reaction [Glucose results in increased expression of TXNIP protein] rhodioloside results in decreased expression of TXNIP protein |
CTD |
PMID:29031534 PMID:37530723 |
|
NCBI chr 1:145,992,435...145,996,579
Ensembl chr 1:145,992,435...145,996,579
|
|
G |
XBP1 |
X-box binding protein 1 |
multiple interactions |
ISO |
rhodioloside inhibits the reaction [furan results in increased expression of XBP1 protein] |
CTD |
PMID:34450210 |
|
NCBI chr22:28,794,560...28,800,569
Ensembl chr22:28,794,555...28,800,597
|
|